Healthcare & Pharmaceuticals

Published by
Boston Globe
|
By |
David Franklin, the drug company whistle-blower who has sparked federal and state investigations into the marketing of the top-selling drug Neurontin, said yesterday that he and his former colleagues engaged in a series of inappropriate tactics, including misleading doctors to persuade them to prescribe the drug for unapproved uses. Read More
Published by
Los Angeles Times
|
By |
Few industries campaigned harder than pharmaceutical manufacturers to elect Republicans to the new Congress, and few industries are better positioned to reap the rewards of the election returns, analysts said Thursday. Read More
Published by
Wired.com
|
By |
Many veterans' advocates believe a certain anthrax vaccine to be a major cause of Gulf War sickness. The company manufacturing it has launched a massive lobbying campaign to persuade the Bush administration to stockpile the controversial drug so it can be administered to civilians. Read More
Published by
OneWorld US
|
By |
AIDS activists are preparing rallies and demonstrations Thursday in several cities around the world to protest against global soft-drink giant Coca-Cola, which they charge must do more to help and treat its HIV-infected workers and their families in sub-Saharan Africa. Read More
Published by
AlterNet
|
By |
The HRT (Hormone Replacement Therapy) scandal is bigger than most think. It's not just about menopausal women, like me, getting bad information from their physicians and the pharmaceutical industry for over 40 years, while the federal government stood by and did nothing. The scandal is much bigger than that. Read More
Published by
Coalition Against Bayer Dangers
|
In Bayer and the Global Compact, Phillipp Mimkes of the Coalition Against Bayer Dangers looks at Bayer's corporate history and why it may be at odds with the Compact, a partnership between the UN and big business. Here, Mimkes offers a few more reasons. Read More
Published by
Coalition Against Bayer Dangers
|
By |
Bayer doesn't just make aspirin--it's a major producer of chemicals and drugs with a dubious corporate record. So how did it get into a partnership with the UN? A German activist tells how and why. Read More
Published by
Village Voice
|
By |
Last week, after its findings revealed that the combination of hormones taken by some 6 million women was doing more harm than good, causing an increase in heart attacks, breast cancer, blood clots, and strokes, a national study was halted mid-stream. Wyeth, which has raked in more than $2 billion a year from its top-selling hormone therapies is now watching its stock price dive. Read More
Published by
The Polaris Institute, Council of Canadians, BIOdevastation, et al.
|
Over the last two years, thousands of people have gathered to counter the annual conventions of the biotechnology industry in Boston and San Diego. This year, people will be converging on Toronto to broaden the biojustice movement and challenge the biotechnology industry and their vision for our future. It will be a gathering to learn, strategize and network about genetic engineering in agriculture and pharmaceuticals, biowarfare, genetic and non-genetic discrimination, trade regimes and corporate control, patenting of life and more. This event is timed to challenge the industry's annual convention BIO2002, Toronto, June 9-12. Read More
* indicates required